]>Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes : Figure 1
105376.fig.001a
(a)
105376.fig.001b
(b)
Figure 1: Scatter plot of shedding data for subjects receiving placebo in the first treatment period. The column labeled HSV-2  + shows data from subjects whose HSV-2 antibody test was positive at enrollment ( 𝑛 = 3 1 ). The horizontal line represents the mean value. The next column shows the individual values for the 3 subjects who were negative for both HSV-1 and HSV-2 antibody; the next column shows the one subject who was HSV-1 antibody positive and HSV2 antibody negative at enrollment. (a) Total HSV-2 shedding, and (b) subclinical shedding.